

Avilar Therapeutics Information
Contact top employees from
Avilar Therapeutics
Summary
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation. Avilar develops ATACs (A...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Estimated Website Traffic
The chart shows a decline in traffic to the avilar-tx.com website. In September, traffic decreased to 221, compared to 242 in the previous month. The highest traffic in 2025 was recorded in August, reaching 242 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Avilar Therapeutics shows a diverse range of experience levels:
8% have been with the company for less than 1 year15% for 1–2 years62% for 3–4 years15% for 5–7 yearsEx-employees positions
In Company
In New Company
Contact top employees from
Avilar Therapeutics
Anthony Monti
Senior Scientist
Martin Freed
Independent Director
Adam Muzikant
Chief Business Officer
Effie Tozzo
Chief Scientific Officer
Margaret Biddle
Senior Director Drug Discovery
Jeni Sideris
Associate Director of Biology
Phil Graham
SVP, Chief Development Officer
Nanqun Zhu
Director, DMPK
Karen Goulet
Executive Assistant
Gejing Deng
Senior Director of Biochemistry and Biophysics
Similar Companies
FAQ
Avilar Therapeutics operates in the Biotechnology industries. More details can be found on the official website: avilar-tx.com.
The headquarters of Avilar Therapeutics are located in Waltham, United States.
Avilar Therapeutics currently employs 10-50 people.